Previous close | 0.9500 |
Open | 0.8200 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 530.00 |
Expiry date | 2024-06-21 |
Day's range | 0.8200 - 0.9500 |
Contract range | N/A |
Volume | |
Open interest | N/A |
The stock market's very rough April saw some of the biggest gainers of the first three months take some of the biggest dings to their market caps. And at the same time, some of the sectors that struggled in Q1 saw a similar reversal of fortune in April.
Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.
Tesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium private-label foods and closes health clinics, and other news to start your day.